COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 280: Articles 2791-2800  | Next

Social contact patterns during the early COVID-19 pandemic in Norway: insights from a panel study, April to September 2020
Veneti, L., Robberstad, B., Steens, A., Forland, F., Winje, B., Vestrheim, D., Jarvis, C., Gimma, A., Edmunds, J., Van Zandvoort, K., de Blasio, B. F.
10.1101/2023.11.18.23298731 — Posted: 2023-11-19
Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients - March 2022 - April 2023.
Bui, D. P., Bajema, K. L., Huang, Y., Yan, L., Li, Y., Rajeevan, N., Berry, K., Rowneki, M., Argraves, S., Hynes, D., Huang, G., Ioannou, G.
10.1101/2023.11.17.23298653 — Posted: 2023-11-18
BFCI at #SMM4H 2023: Integration of Machine Learning and TF-IDF for Covid-19 Tweets Analysis
Nayel, H., Ashraf, N., Aldawsari, M.
10.1101/2023.11.18.23297862 — Posted: 2023-11-18
Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021 to June 2022
Sandford, R., Yadav, R. L., Noble, E. K., Sumner, K. M., Joshi, D. J., Tartof, S. Y., Wernli, K. J., Martin, E. T., Gaglani, M., Zimmerman, R., Talbot, H. K., Grijalva, C. G., Belongia, E. A., Carlson, C., Coughlin, M., Flannery, B. M., Pearce, B., Rogier, E.
10.1101/2023.11.17.23298700 — Posted: 2023-11-18
Impact of State Telehealth Parity Laws for Private Payers on Hypertension Management before and during the COVID-19 Pandemic
Zhang, D., Lee, J. S., Popoola, A., Lee, S., Jackson, S. L., Pollack, L. M., Dong, X., Luo, F., Therrien, N. L.
10.1101/2023.11.16.23298658 — Posted: 2023-11-18
Unveiling the Emotional Turmoil: How Covid-19 impacted researchers and the pursuit of emotional well-being in academia.
Weise, C., Sole-Suner, N., Corcelles, M., Sala-Bubare, A., Castello, M.
10.1101/2023.11.15.567306 — Posted: 2023-11-17
Spatially resolved single-cell atlas of the lung in fatal Covid19 in an African population reveals a distinct cellular signature and an interferon gamma dominated response
Nyirenda, J., Hardy, O., Silva Filho, J. L., Herder, V., Attipa, C., Ndovi, C., Siwombo, M., Namalima, T., Suwedi, L., Nyasulu, W., Ngulube, T., Nyirenda, D., Mvaya, L., Phiri, J., Chasweka, D., Eneya, C., Makwinja, C., Phiri, C., Ziwoya, F., Tembo, A., Makwangwala, K., Khoswe, S., Banda, P., Morton, B., Hilton, O., Lawrence, S., Frere dos Reis, M., Cardoso Melo, G., Vinicious Guimaros de Lecerda, M., Trindande Maranhao Costa, F., Marcelo Monteiro, W., Carlos de Lima Fereirra, L., Johnson, C., Mcguinness, D., Jambo, K., Haley, M. J., Kumwenda, B., Palmarini, M., Barnes, K. G., Denno, D. M., Voskuijl, W., Kamiza, S., Couper, K., Marti, M., Otto, T. D., Moxon, C. A.
10.1101/2023.11.16.566964 — Posted: 2023-11-17
Dynamic label-free analysis of SARS-CoV-2 infection reveals virus-induced subcellular remodeling.
Saunders, N., Monel, B., Cayet, N., Archetti, L., Moreno, H., Jeanne, A., Marguier, A., Wai, T., Schwartz, O., Frechin, M.
10.1101/2023.11.16.567378 — Posted: 2023-11-17
Human microbiota is a reservoir of SARS-CoV-2 advantageous mutations
Cao, B., Wang, X., Yin, W., Gao, Z., Xia, B.
10.1101/2023.11.16.567485 — Posted: 2023-11-17
Identification of mouse CD4+ T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramers
Bricio Moreno, L., Barreto de Albuquerque, J., Neary, J. M., Nguyen, T., Hastie, K. M., Landeras-Bueno, S., Hariharan, C., Nathan, A., Getz, M. A., Gayton, A. C., Khatri, A., Gaiha, G. D., Saphire, E. O., Luster, A. D., Moon, J. J.
10.1101/2023.11.16.566918 — Posted: 2023-11-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).